Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust

Psychopharmacology

Volumn 185, Issue 4, 2006, Pages 529-535

  Kamboj, S K ^a   Curran, H V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anger; Anticholinergic; Benzodiazepine; Disgust; Emotion recognition; Lorazepam; Scopolamine

Indexed keywords

LORAZEPAM; PLACEBO; SCOPOLAMINE;

ADULT; AGGRESSION; ANGER; ANTEROGRADE AMNESIA; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMOTION; FACIAL EXPRESSION; FEAR; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RECOGNITION; TRANQUILIZING ACTIVITY;

ADOLESCENT; ADULT; ANGER; DEPRESSION, CHEMICAL; DOUBLE-BLIND METHOD; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MALE; MEMORY; MUSCARINIC ANTAGONISTS; PSYCHOMOTOR PERFORMANCE; RECOGNITION (PSYCHOLOGY); SCOPOLAMINE;

EID: 33645458936     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0332-4     Document Type: Article

References (42)

1. Bentley P, Vuilleumier P, Thiel CM, Driver J, Dolan RJ (2003) Cholinergic enhancement modulates neural correlates of selective attention and emotional processing. Neuroimage 20:58-70
2. Blair RJR, Curran HV (1999) Selective impairment in the recognition of anger induced by diazepam. Psychopharmacology 147:335-338
3. Bond AJ, Lader MH (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218
4. Bond AJ, Curran HV, Bruce M, O'Sullivan G, Shine P (1995) Behavioural aggression in panic disorder after 8 weeks treatment with alprazolam. J Affect Disord 35:117-123
5. Bradley WG, Daroff RB, Fenichel GM, Marshal CD (2000) Neurology in clinical practice, 3rd edn. Butterworth Heinemann, Boston, MA
6. Brown MW, Brown J, Bowes JB (1989) Absence of priming coupled with substantially preserved recognition in lorazepam-induced amnesia. Q J Exp Psychol 41A:599-617
7. Calabresi P, Centonze D, Gubellini P, Pisani A Bernardi G (2000) Acetylcholine-mediated modulation of striatal function. Trends Neurosci 23:120-126
8. Calder AJ, Young AW, Rowland D, Perrit DI, Hodges JR, Etcoff NL (1996) Facial emotion recognition after bilateral amygdala damage: differentially severe impairment of fear. Cogn Neuropsychol 13:699-745
9. Calder AJ, Lawrence AD, Young AW (2001) Neuropsychology of fear and loathing. Nat Rev Neurosci 2:352-363
10. Calder AJ, Keane J, Lawrence AD, Manes F (2004) Impaired recognition of anger following damage to the ventral striatum. Brain 127:1958-1969
11. Curran HV (2000) The psychopharmacology of memory. In: Tulving E, Craik F (eds) The Oxford handbook of memory. Oxford Univ. Press, New York
12. Curran HV, Weingartner (2002) Psychopharmacology of human memory. In: Baddelely AD, Kopelman MD, Wilson BA (eds) Handbook of memory disorders. Wiley
13. Curran HV, Pooviboonsuk P, Dalton JA, Lader MH (1998) Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology 135:27-36
14. Di Chiara G, Morelli M, Consolo S (1994) Modulatory function of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17:228-233
15. Ekmann P, Friesen WV (1976) Pictures of facial affect. Consulting Psychology, Palo Alto, CA
16. Everitt BJ, Robbins TW (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48:649-684
17. Fernandez-Duque D, Black SE (2005) Impaired recognition of negative facial emotions in patients with frontotemporal dementia. Neuropsychologia 43:1673-1687
18. Giersch A, Herzog MH (2004) Lorazepam strongly prolongs visual information processing. Neuropsychopharmacology 29:1386-1394
19. Grey JM, Young AW, Barker WA, Curtis A, Gibson D (1997) Impaired recognition of disgust in Huntington's disease gene carriers. Brain 120:2029-2038
20. Hall RCW, Zisook S (1981) Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol 11:99S-104S
21. Hargrave R, Maddock RJ, Stone V (2002) Impaired recognition of facial expressions of emotion in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 14:64-71
22. Harmer CJ, Perrett DI, Cowen PJ, Goodwin GM (2001) Administration of the beta-adrenoceptor blocker propranolol impairs the processing of facial expressions of sadness. Psychopharmacology 154:383-389
23. Harmer CJ, Hill SA, Taylor MJ, Cowen PJ, Goodwin GM (2003a) Towards a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Am J Psychiatry 160:990-992
24. Harmer CJ, Bhagwagar Z, Perrett DI, Völlum BA, Cowen PJ, Goodwin GM (2003b) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28:148-152
25. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161:1256-1263
26. Hennenlotter A, Schroeder U, Erhard P, Haslinfer B, Stahl R Weindl A, von Einsiedel HG, Lange KW, Ceballos-Baumann AO (2004) Neural correlates associated with impaired disgust processing in pre-symptomatic Huntington's disease. Brain 127:1446-1453
27. Holland PC, Gallagher M (1999) Amygdala circuitry in attentional and representational processes. Trends Cogn Sci 3:65-73
28. Lawrence AD, Calder AJ, McGowan SW, Grasby PM (2002) Selective disruption of the recognition of facial expressions of anger. Neuroreport 13:881-884
29. Mesulam M (2004) The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 11:43-49
30. Mesulam M-M, Mufson EJ, Levey AI, Wainer BH (1983) Cholinergic innervation of cortex by basal forebrain: cytochemistry and cortical connection of the septal area, diagonal band nuclei, nucleus basalis and hypothalamus in rhesus monkey. J Comp Neurol 214:170-197
31. Mesulam M-M, Hersh LB, Mash DC, Geula C (1992) Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study. J Comp Neurol 318:316-328
32. Mintzer MZ, Griffiths RR (2003) Lorazepam and scopolamine: a single dose comparison of effects on human memory and attentional processes. Exp Clin Psychopharmacol 11:56-72
33. Möhler H, Fritschy JM, Rudolph U (2002) A new benzodiazepine pharmacolgy. J Pharmacol Exp Ther 300:2-8
34. Nelson H, Willison J (1991) National adult reading test, 2nd edn. NFER-Nelson, Windsor
35. Rosenbaum JF, Woods SW, Groves JE, Klerman GL (1984) Emergence of hostility during alprazolam treatment. Am J Psychiatry 141:792-793
36. Sprengelmeyer R, Young AW, Calder AJ, Karnat A, Lang HW Homberg et al (1996) Loss of disgust: perception of faces and emotions in Huntington's disease. Brain 119:1647-1665
37. Sprengelmeyer R, Young AW, Mahn K, Schroeder U, Woitalla D, Buttner T, Kuhn W, Przuntek H (2003) Facial expression recognition in people with medicated and unmedicated Parkinson's disease. Neuropsychologia 41:1047-1057
38. Thiel CM, Henson RNA, Dolan RJ (2002) Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study. Neuropsychopharmacology 27:282-292
39. Wager TD, Phan KL, Liberzon, Taylor (2003) Valence, gender and lateralisation of functional brain anatomy in emotion: a meta-analysis of findings from neuroimaging. Neuroimage 19:513-531
40. Whalen P (1999) Fear, vigilance, and ambiguity: initial neuroimaging studies of the human amygdala. Curr Dir Psychol Sci 7:177-187
41. Wilson B, Cockburn J, Baddeley A (1985) The Rivermead behavioural memory test. Thames Valley Test, Titchfield
42. Zangara A, Blair RJR, Curran HV (2002) A comparison of the effects of a β-adrenergic blocker and a benzodiazepine upon the recognition of human facial expressions. Psychopharmacology 163:36-41